Trials / Terminated
TerminatedNCT02864355
Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this prospective, randomized controlled study is to ascertain whether the perioperative use of the FloTrac device to guide fluid and vasopressor management during esophagectomy improves patient outcomes. The primary outcome is cardiopulmonary complications; however, the secondary outcome of decreasing patient morbidity (acute renal injury, anastomotic leak, and overall length of both ICU (intensive care unit) and hospital stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Goal Directed Therapy | Participants in this group will have a FloTrac monitor attached to their arterial line and the Goal Directed Therapy algorithm will be followed to manage blood pressures. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2016-08-12
- Last updated
- 2021-03-02
- Results posted
- 2021-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02864355. Inclusion in this directory is not an endorsement.